RediNews
ETFs Holding VRTX »    VRTX Historical Stock Prices »
VRTX News Video: Fri, Apr 5, 2019, 10:28 AM — Nasdaq 100 Movers: INTC, ALGN


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vertex Pharmaceuticals is primarily developing and commercializing therapies for the treatment of cystic fibrosis (CF). Co.'s marketed products are ORKAMBI (lumacaftor in combination with ivacaftor), KALYDECO (ivacaftor) and SYMDEKO (tezacaftor in combination with ivacaftor), which are approved to treat CF patients in North America, Europe and Australia with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene. Co. is also developing VX-150 and VX-128 as treatments for pain, co-developing CTX001, for the treatment of beta-thalassemia and sickle cell disease, and VX-210 as a treatment for acute spinal cord injury. Self directed investors in Vertex Pharmaceuticals, Inc. will be interested in keeping up with all Vertex Pharmaceuticals, Inc. news they can find, both VRTX news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on VRTX. At RediNews, we simplify this task by presenting both VRTX news releases originating from Vertex Pharmaceuticals, Inc. itself, and VRTX news from a variety of media outlets. Visitors can browse this news online and through our VRTX RSS news feed.

VRTX News

VRTX News — Articles, Videos, & Press Releases

Analysts Predict 12% Upside For The Holdings of QQEW
11 hours, 2 minutes ago — ETF Channel
VRTX June 28th Options Begin Trading
Monday, May 13, 2019, 10:46 AM — Stock Options Channel
Noteworthy Friday Option Activity: VRTX, AAXN, TRXC
Friday, May 10, 2019, 3:27 PM — Stock Options Channel
CELG vs. VRTX: Which Stock Should Value Investors Buy Now?
Wednesday, May 8, 2019, 7:30 AM — Zacks
IBB, BIIB, VRTX, ILMN: Large Outflows Detected at ETF
Tuesday, May 7, 2019, 10:49 AM — ETF Channel
Proteostasis (PTI) to Post Q1 Earnings: What's in Store?
Tuesday, May 7, 2019, 8:47 AM — Zacks
Vertex (VRTX) Q1 Earnings and Revenues Surpass Estimates
Wednesday, May 1, 2019, 9:46 AM — Zacks
What's in Store for Vertex (VRTX) This Earnings Season?
Wednesday, April 24, 2019, 2:32 PM — Zacks
Sum Up The Pieces: QQXT Could Be Worth $58
Thursday, April 18, 2019, 8:10 AM — ETF Channel
Vertex Pharmaceuticals Becomes Oversold (VRTX)
Wednesday, April 17, 2019, 4:28 PM — Dividend Channel
Notable Wednesday Option Activity: TNDM, VRTX, LLY
Wednesday, April 17, 2019, 3:18 PM — Stock Options Channel
VRTX Makes Notable Cross Below Critical Moving Average
Wednesday, April 17, 2019, 11:50 AM — Market News Video
iShares Nasdaq Biotechnology ETF Experiences Big Outflow
Wednesday, April 17, 2019, 11:19 AM — ETF Channel
Vertex, CRISPR's Gene Editing Drug Gets FDA's Fast Track Tag
Wednesday, April 17, 2019, 5:14 AM — Zacks
IBB, GILD, CELG, VRTX: ETF Outflow Alert
Tuesday, April 9, 2019, 10:52 AM — ETF Channel
IBB, GILD, CELG, VRTX: Large Outflows Detected at ETF
Monday, April 1, 2019, 10:56 AM — ETF Channel
4 Small Biotech Stocks Likely to Witness More Upside in 2019
Friday, March 29, 2019, 8:36 AM — Zacks
Proteostasis Plunges on Weak Data From Cystic Fibrosis Study
Tuesday, March 26, 2019, 10:11 AM — Zacks
May 3rd Options Now Available For Vertex Pharmaceuticals (VRTX)
Monday, March 25, 2019, 10:50 AM — Stock Options Channel
First Week of VRTX May 17th Options Trading
Friday, March 22, 2019, 10:41 AM — Stock Options Channel
First Week of VRTX October 18th Options Trading
Thursday, March 21, 2019, 10:51 AM — Stock Options Channel
CELG vs. VRTX: Which Stock Is the Better Value Option?
Wednesday, March 13, 2019, 7:30 AM — Zacks
Peek Under The Hood: SPHQ Has 10% Upside
Monday, March 11, 2019, 8:14 AM — ETF Channel
Why Is Vertex (VRTX) Down 0.7% Since Last Earnings Report?
Thursday, March 7, 2019, 8:31 AM — Zacks
CRISPR Therapeutics Up as Dosing Starts in Thalassemia Study
Tuesday, February 26, 2019, 9:54 AM — Zacks
Groupon (GRPN) to Report Q4 Earnings: What's in the Cards?
Monday, February 11, 2019, 7:05 AM — Zacks
Exelon Takes Over #117 Spot From Vertex Pharmaceuticals
Thursday, February 7, 2019, 4:38 PM — Market News Video
Analysts Anticipate RPG Will Reach $121
Thursday, February 7, 2019, 7:40 AM — ETF Channel
March 22nd Options Now Available For Vertex Pharmaceuticals (VRTX)
Thursday, January 31, 2019, 11:06 AM — Stock Options Channel
Intel Becomes #49 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals
Tuesday, January 29, 2019, 12:32 PM — Market News Video
Noteworthy Friday Option Activity: VRTX, EXAS, WIN
Friday, January 11, 2019, 3:17 PM — Stock Options Channel
VRTX March 1st Options Begin Trading
Thursday, January 10, 2019, 11:08 AM — Stock Options Channel
Bullish Two Hundred Day Moving Average Cross - VRTX
Thursday, January 3, 2019, 12:18 PM — Market News Video
First Week of February 15th Options Trading For Vertex Pharmaceuticals (VRTX)
Thursday, January 3, 2019, 11:14 AM — Stock Options Channel
Noteworthy Friday Option Activity: DVMT, VRTX, PXD
Friday, December 21, 2018, 3:21 PM — Stock Options Channel
Analysts Expect QQXT To Hit $58
Thursday, December 20, 2018, 7:55 AM — ETF Channel
Notable Thursday Option Activity: PDFS, VRTX, WDC
Thursday, December 13, 2018, 3:19 PM — Stock Options Channel
Vertex Pharmaceuticals Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Intuit
Wednesday, November 28, 2018, 2:24 PM — Market News Video
Noteworthy Tuesday Option Activity: AVGO, VRTX, TIF
Tuesday, November 27, 2018, 1:24 PM — Stock Options Channel
VRTX Crosses Above Key Moving Average Level
Tuesday, November 27, 2018, 11:22 AM — Market News Video
VRTX January 2019 Options Begin Trading
Wednesday, November 21, 2018, 11:43 AM — Stock Options Channel
First Week of VRTX July 2019 Options Trading
Wednesday, November 21, 2018, 10:46 AM — Stock Options Channel
Add Up The Parts: SPHQ Could Be Worth $35
Monday, November 19, 2018, 7:27 AM — ETF Channel
Vertex Pharmaceuticals Takes Over #127 Spot From Target
Thursday, November 1, 2018, 4:38 PM — Market News Video
Vertex Pharmaceuticals Achieves #43 Analyst Rank, Surpassing NRG Energy
Thursday, November 1, 2018, 12:03 PM — ETF Channel
VRTX December 7th Options Begin Trading
Thursday, October 25, 2018, 11:32 AM — Stock Options Channel
Notable Friday Option Activity: OFG, VRTX, CRC
Friday, October 19, 2018, 3:17 PM — Stock Options Channel
The Implied Analyst 12-Month Target For XLV
Friday, October 19, 2018, 7:48 AM — ETF Channel
Thursday Sector Laggards: Industrial, Healthcare
Thursday, October 18, 2018, 2:32 PM — Market News Video
November 23rd Options Now Available For Vertex Pharmaceuticals (VRTX)
Thursday, October 4, 2018, 11:22 AM — Stock Options Channel
Interesting VRTX Put And Call Options For November 9th
Thursday, September 27, 2018, 11:18 AM — Stock Options Channel
First Week of VRTX January 2021 Options Trading
Tuesday, September 18, 2018, 10:58 AM — Stock Options Channel
Notable Friday Option Activity: DIS, ALGN, VRTX
Friday, September 14, 2018, 3:24 PM — Stock Options Channel
November 2nd Options Now Available For Vertex Pharmaceuticals (VRTX)
Thursday, September 13, 2018, 11:21 AM — Stock Options Channel
Interesting VRTX Put And Call Options For October 26th
Thursday, September 6, 2018, 11:31 AM — Stock Options Channel
PBE, ILMN, BIIB, VRTX: ETF Inflow Alert
Thursday, September 6, 2018, 11:02 AM — ETF Channel
Notable Friday Option Activity: WDAY, VRTX, DE
Friday, August 24, 2018, 3:19 PM — Stock Options Channel
Interesting VRTX Put And Call Options For October 5th
Thursday, August 23, 2018, 11:02 AM — Stock Options Channel
First Week of April 2019 Options Trading For Vertex Pharmaceuticals (VRTX)
Tuesday, August 21, 2018, 10:56 AM — Stock Options Channel
Implied FTC Analyst Target Price: $73
Tuesday, July 31, 2018, 7:55 AM — ETF Channel
Interesting VRTX Put And Call Options For September 21st
Tuesday, July 24, 2018, 12:31 PM — Stock Options Channel
Raytheon Achieves #38 Analyst Rank, Surpassing Vertex Pharmaceuticals
Monday, July 23, 2018, 11:47 AM — ETF Channel
Noteworthy Friday Option Activity: OLED, SENS, VRTX
Friday, June 29, 2018, 3:18 PM — Stock Options Channel
Interesting VRTX Put And Call Options For August 17th
Monday, June 25, 2018, 10:42 AM — Stock Options Channel
VRTX August 3rd Options Begin Trading
Thursday, June 21, 2018, 11:51 AM — Stock Options Channel
Bullish Two Hundred Day Moving Average Cross - VRTX
Thursday, June 14, 2018, 4:48 PM — Market News Video
The Implied Analyst 12-Month Target For FBT
Monday, June 11, 2018, 8:00 AM — ETF Channel
VRTX July 27th Options Begin Trading
Thursday, June 7, 2018, 11:05 AM — Stock Options Channel
Vertex Pharmaceuticals Enters Oversold Territory
Tuesday, June 5, 2018, 11:58 AM — Dividend Channel
July 13th Options Now Available For Vertex Pharmaceuticals (VRTX)
Thursday, May 31, 2018, 11:16 AM — Stock Options Channel
iShares Nasdaq Biotechnology ETF Experiences Big Outflow
Tuesday, May 29, 2018, 11:36 AM — ETF Channel
July 6th Options Now Available For Vertex Pharmaceuticals (VRTX)
Thursday, May 24, 2018, 11:30 AM — Stock Options Channel
IBB, BIIB, CELG, VRTX: ETF Outflow Alert
Monday, May 21, 2018, 11:06 AM — ETF Channel
VRTX is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

COO News
CSU News
CNC News
CYCC News
EW News
BMY News
ESRX News
MDT News
FRX News
PRGO News

If you use web portal software to control your web site content, chances are your portal software already makes it easy for you to integrate RSS feeds from third party sources, like RediNews. Using RSS — short for Really Simple Syndication — makes content syndication a snap, so even if you have never worked with a stock data feed before, you should still have no problem working with the content delivery mechanism made possible by RSS. These RediNews RSS feeds are found throughout our website wherever news is found, whether by sector or custom content by symbol, by clicking the RSS icon for any news page (which will look like this): .

VRTX News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.